What Is Patent Registry Publicity? IMPI, COFEPRIS, and the State’s Contradiction

The State’s recognition of an industrial property right is one of the legal acts with the greatest significance in the configuration of contemporary markets and the sustained promotion of technological innovation. Yet traditional legal interpretation and administrative practice have tended to isolate this phenomenon from its systemic context, reducing it to the issuance of a title that grants a temporary monopoly of exploitation. Under that restrictive view, the central debate in patent law appears exhausted by technical analysis of patentability requirements —novelty, inventive step, and industrial application— and by the formal recognition issued by the competent authority. That approach omits a material dimension that is fundamental to the survival of the rule of law in economic life:

The underlying problem does not lie only in the formal and isolated recognition of a patent, but in the stark contradiction that arises when the same State that records and publicizes a right later acts, through its regulatory agencies, as if that right did not exist.

Patent registry publicity has been progressively stripped of its relevance in legal debate, treated by operators and regulators as a passive notice formality or a simple repository of technical information.

Registry publicity is the cornerstone on which legal predictability, institutional coherence, and protection against arbitrary public power are built.

When an invention, after substantive examination, enters the Industrial Property Gazette, the State is not merely archiving a technical file. It is issuing a declaration with absolute material effects, organizing legitimate legal expectations and necessarily conditioning the conduct of all market actors, including the State apparatus itself.

The deterioration of legal trust, increasingly common in complex administrative architectures, materializes precisely through administrative dissonance and contradiction. If one State entity grants, certifies, and publicizes an exclusive right while another agency of that same State issues general rules, regulatory authorizations, or marketing authorizations that facilitate, encourage, or directly ignore that right, a direct contradiction emerges. Patent registry publicity then ceases to operate as a structural guarantee for the inventor and society, becoming a sterile formality incapable of providing objective legal certainty.

The pathology does not end in a single administrative mechanism. The State’s contradiction of itself may appear in general rules defining the evidence required to prove interchangeability of generic medicines against a still-patented innovator product; in public procurement terms that award third parties the supply of products whose commercial exploitation invades valid claims; in import or marketing authorizations issued without regard to the registry; in Mexican Official Standards regulating technical specifications associated with patented inventions; and even in tax or customs criteria that disregard the published exclusive right. All share the same structure: one State agency acts as if the right recorded, examined, and published by another agency did not exist. This article deliberately focuses on pharmaceutical linkage between IMPI and COFEPRIS because it is the most documented, litigated, and doctrinally developed paradigm in Mexico.

The purpose of this analysis is to develop a substantive theory of the material function of registry publicity in the patent system, removing it from a merely informational understanding and placing it within the general theory of administrative and registry law. The central thesis is that registration and publication constitute an irreplaceable structural guarantee of legal predictability, State coherence, material opposability, and protection of legitimate expectations. When the State hides behind internal fragmentation to weaken the effects of what it has recorded and published, it does not only violate a private patrimonial right; it damages the systemic function of the public registry and the legal infrastructure that sustains economic and scientific development.

II. Why is it wrong to treat the patent registry as an administrative archive?

To understand the crisis facing registry publicity in patent law, it is useful to look inward to analogous institutions in private patrimonial law. In civil law and real estate law, registry theory has reached a high level of sophistication. The property registry is not designed to archive historical documents or keep a passive census of wealth, but to provide opposability, certainty, stability, and structure to legal relations. Private property requires a publicity system that removes clandestinity from legal transactions. By contrast, when the analysis moves to industrial property, and specifically to patent-granting systems, a reduced, mechanistic, and administrative view of the registry tends to prevail.

That view conceives the patent registry, administered by national offices, as an inert repository of files: a technical catalogue whose function is predominantly taxonomic and evidentiary.

This mistaken idea of registry publicity as a purely informational phenomenon distorts the structure of exclusive rights. Registry doctrine requires a sharp distinction between formal publicity and material registry publicity. Formal publicity concerns access to the information contained in registry entries. Material registry publicity concerns the substantive, presumptive, and immediate effects that the law attaches to what has been recorded. It does not merely make a fact known; it makes a legal situation opposable.

Treating the patent registry as a mere archive empties it of dogmatic content. An archive receives, classifies, and preserves information passively. A legal registry receives information, subjects it to qualification under a legality standard, publishes it, and through that publication transforms the preexisting legal reality.

The patent registry is not a passive mirror of the law, but a living infrastructure of coordination that organizes economic conduct and regulatory expectations around innovation. When IMPI publishes the grant of a patent in the Industrial Property Gazette, it defines the borders of the market. It establishes an invisible but legally impenetrable perimeter of exclusivity that imposes duties of abstention not only on private parties, but on every entity that forms part of the State.

The contrast between registry-as-archive and registry-as-legal-coordination exposes the theoretical gap in regulatory and administrative enforcement around industrial property. In the structure defended here, material registry publicity in intellectual property is not an accessory or secondary formality. It is the sine qua non condition for an ordered, predictable, and fair market.

The act of registry publication extracts the exclusive right from secrecy and the inventor’s private sphere, projecting it into the public sphere and turning it into an undeniable legal fact.

III. Registry publicity and the systemic function of the State

To understand the true weight of registry publicity in patent law, the analysis must move beyond the bilateral relationship between the sovereign State that grants a title and the private party that receives it. Contemporary registry law teaches that registry publicity has a deep institutional dimension tied to the systemic function of the modern State. At that level, publicity-opposability, publicity-legitimation, and publicity-guarantee operate simultaneously.

The theory of public faith in the registry was born in civil and real estate doctrine, but it has a direct and necessary echo in industrial property. In the patent registry, public faith means that the State, through its specialized agencies, gives the recorded matter a presumption of accuracy, validity, and novelty. That presumption produces substantive, material, and procedural effects that improve the position of the registered holder.

Registration is therefore the most complete manifestation of the State’s protective will: the dogmatic instrument through which public power assumes responsibility for ensuring that a legally qualified and published situation will be respected erga omnes.

The critical corollary is that the registry does not only bind private parties in a competitive market. Primarily, registry publicity conditions the coherent conduct of the State apparatus itself. Public registries, including industrial, commercial, and health-control registries, must obey common causes and higher directives that express the unitary action of the State.

Contemporary administrative law rests on the principle of unity of administrative action. Although the State is internally divided into ministries, commissions, institutes, and prosecutors, it remains a single entity before the citizen. Its conduct cannot be arbitrary or contradictory. The principle requires teleological cohesion in the exercise of public power, even where agencies possess technical autonomy.

The institutional dimension of the registry therefore requires that what the specialized industrial-property branch recognizes, certifies, and publishes as a valid patent be assimilated and respected by the health-control branch, the public-procurement branch, and every other relevant authority. When one agency ignores the material effects of a patent validly recorded in a registry administered by another, the systemic function of the registry is breached.

IV. What is the material dimension of opposability?

Opposability is one of the strongest concepts in general legal theory. Classically, it is the legal capacity to assert a right or legal situation against everyone else in society: the erga omnes effect. In patent law, however, the protected object is immaterial, and its exploitation is mediated by additional administrative regimes, especially health, environmental, and commercial regulation.

The practical effects of material registry publicity consist in moving exclusivity from legal abstraction into the economic and procedural reality of the market. Through publication in the Industrial Property Gazette, IMPI issues an act of authority that materializes and makes opposability visible.

The legal analysis becomes useless if it is confined to horizontal relationships among private competitors. The core of the modern problem lies in regulators and in the framework within which markets operate. Registered acts endowed with material publicity must take full effect both among private parties and before public authorities. Opposability therefore has a horizontal dimension and a vertical dimension. The regulator is not outside the patent’s opposability; it is the first passive subject required to align its administrative conduct with the legal truth produced by the registry.

Opposability loses its practical meaning if other spheres of authority within the same State may disregard the material effects of the registry. A patent title is of little use if another government agency, operating under another statute, authorizes a third party to commercialize the protected product and provides the administrative vehicle needed to complete the infringement in the market.

V. IMPI, COFEPRIS, and administrative contradiction

The most revealing paradigm in Mexico is the pharmaceutical linkage system. This mechanism, introduced through Article 167 Bis of the Health Supplies Regulation, Article 47 bis of the former Industrial Property Law Regulation, and now the final paragraph of Article 162 of the Federal Law for the Protection of Industrial Property, was designed to coordinate COFEPRIS and IMPI so that marketing authorizations for allopathic medicines respect valid industrial property rights.

The linkage system operates through two formal instruments of registry publicity: the Industrial Property Gazette administered by IMPI, and the specialized Medicines Gazette, where patents associated with allopathic medicines are published. In theory, a generic manufacturer seeking marketing authorization must show the health authority that its application does not invade the published patent rights. It is a preventive administrative-protection mechanism.

The point here is not to describe the ideal procedure, but to examine how administrative contradiction consumes the registry in practice. IMPI and COFEPRIS have historically operated as administrative silos, responding to incompatible legal logics, market pressures, public-health urgencies, and political timelines.

Recent institutional efforts deserve recognition: the Technical Collaboration Agreement between IMPI and COFEPRIS, published in the Official Gazette of the Federation on March 6, 2025, and the 2026 launch of the IMPI-COFEPRIS Linkage System Portal, which centralizes public access to marketing authorizations, third-party oppositions, patents nearing expiration, the gazette of patents associated with allopathic medicines, and response letters between the authorities. But those advances still operate on an insufficient institutional design: coordination is structured as technical cooperation and aggregated publicity, not as a legally binding unity of action. The result is a field of incompatible regulatory signals.

IMPI’s refusal to publish certain patent categories in the Medicines Gazette, or COFEPRIS’s administrative omission in the face of a patent validly recorded in the Industrial Property Gazette, are not merely technical errors. They are an institutional tension between the registry that materially publicizes a property right and the health authorization that enables harmful commercial exploitation.

When COFEPRIS, without the required coordination, issues a marketing authorization for a generic product covered by the claims of a valid patent granted by IMPI, the Mexican State contradicts itself.

That contradiction weakens legal certainty beyond the economic losses of the specific case. In a system that chronically displays this pathology, the central patent registry loses its ability to coordinate the market fairly, because the largest incentive for large-scale infringement is supplied and administratively validated by a branch of the federal public administration.

Pharmaceutical linkage thus becomes a recurring conflict zone where the coordinating efficacy of the public registry and the teleological cohesion of the State fail, showing how administrative fragmentation limits the material value of registry publicity and leaves the inventor in an unacceptable state of vulnerability.

VI. Registry publicity, legitimate expectations, and legal certainty

The administrative contradiction described above not only creates market inefficiencies and discourages research and development. It directly attacks the pillars of administrative law and the rule of law. One of those pillars is the protection of legitimate expectations, historically developed in German public law under the concept of Vertrauensschutz and now reflected in Latin American constitutional systems as an expression of legal certainty.

The principle holds that when formal and continuous public action creates justified confidence in the stability of prior State acts or in the validity of a legal situation, that situation cannot be unpredictably or arbitrarily altered by the State itself. In patent law, the grant, title, and publication of a patent in the Industrial Property Gazette generates the highest level of legitimate expectation imaginable in administrative law.

Closely connected is the State’s own-acts doctrine, captured by the Latin maxim venire contra factum proprium non valet. If legally relevant conduct by a public authority creates material expectations, the originator of that conduct cannot later contradict it to the detriment of the governed person who relied on the first act.

Objective legal certainty depends directly on the respect that public authorities show toward registry publicity. The prohibition of arbitrariness forbids irrational, disproportionate, or incongruent exercises of public power. Ignoring the national patent registry to facilitate, through omission or procedural deficiency, the entry of infringing third parties into the market is one of the clearest expressions of administrative arbitrariness.

formal recognition and material publicity by the State are not a sufficient guarantee of material economic protection.

VII. Conclusion

A contemporary understanding of the patent registry requires urgent emancipation from the bureaucratic and procedural view that has historically suffocated its study. The industrial property registry is not a warehouse of passive technical information. In its deeper institutional and legal meaning, it is the foundation on which a modern society’s economic and legal expectations are articulated, legitimated, and sustained. By conferring publicity and opposability, the registry draws the boundaries of lawful economic conduct, encourages technological development, and guarantees the institutional coherence of the State.

To recognize that material registry publicity is endowed with public faith and absolute opposability is to accept that it imposes non-waivable legal duties. Those duties are not directed only at private competitors. They are directed, primarily and vertically, at the public administration itself. Under the principle of unity of State action, it is unacceptable for the government apparatus to fragment its regulatory functions and permit different agencies to act against the legal truth that the State itself recognized.